A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy
This study is currently recruiting participants.
Verified January 2013 by Takeda Global Research & Development Center, Inc.
Study NCT01568385
Information provided by Takeda Global Research & Development Center, Inc.
First Received on March 29, 2012.
Last Updated on January 17, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
